Northern Trust expands OTC derivatives aid

Northern Trust, the Chicago- based buy-side firm with $756 billion under management, has expanded its OTC derivatives coverage to include independent valuations of a range of derivatives for its custody, fund administration and investment operations outsourcing clients. The firm can now connect to third-party providers of OTC derivatives valuations, using a system of tolerance checks to achieve optimum pricing and performance measurement for complex financial instruments. The initiative also

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: